Prediction of metabolic syndrome among postmenopausal Ghanaian women using obesity and atherogenic markers

Lipids in Health and Disease

Volumn 11, Issue , 2012, Pages

  Arthur, Fareed K N ^a   Adu Frimpong, Michael ^a   Osei Yeboah, James ^b   Mensah, Faustina O ^a   Owusu, Lawrence ^c  

^a KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^b Department of Health Information Management   (Ghana)

^c DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Abdominal adiposity; Insulin resistance; Metabolic syndrome; Postmenopausal and premenopausal women

Indexed keywords

ATHEROGENIC MARKER; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; MARKER; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BODY HEIGHT; BODY MASS; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; OBESITY; POSTMENOPAUSE; PREDICTION; PREMENOPAUSE; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; AGED; AREA UNDER CURVE; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; FEMALE; GHANA; HUMANS; LIPIDS; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; POSTMENOPAUSE; RISK FACTORS; ROC CURVE; WAIST CIRCUMFERENCE; WAIST-HIP RATIO; YOUNG ADULT;

EID: 84864816399     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-11-101     Document Type: Article

References (48)

1. Adipocytokines: leptin-the classsical, resistin-the controversial, adiponectin- the promissing, and more to come. Koerner A, Kratzsch J, Kiess W, Best Pract Res Clin Endocrinol Metab 2005 19 525 546 10.1016/j.beem.2005.07.008 16311215 (Pubitemid 41819217)
2. Adiponectin as a potential key player in metabolic syndrome. Insights into atherosclerosis, diabetes and cancer. Funahashi T, Matsuzawa Y, Kihara S, Int Congr Ser 2004 1262 368 371
3. The Metabolic syndrome. Fulom T, Tessier D, Carpentier A, Patholog Biol 2006 54 375 386 10.1016/j.patbio.2006.07.002 (Pubitemid 44468297)
4. Hormonal Therapy of menopause. Paszkowski T, Kodnicka M, Menopause 2007 2 106 109
5. Racial disparities in metabolism, central obesity, and sex hormone-binding globulin in postmenopausal women. Berman D, Rodrigues L, Nicklas B, J Clin Endocrinol Metab 2001 86 97 103 10.1210/jc.86.1.97 11231984 (Pubitemid 32109781)
6. Changes in energy balance and body composition at menopause. A controlled londitudinal study. Poehlman E, Toth M, Gardner A, Ann Intern Med 1995 123 673 675 7574222
7. Association of multiple risk factors and insulin resistance with increased prevalence of asymptomatic coronary artery disease by an electron-beam computed tomographic study. Arad Y, Newstein D, Cadet F, Arterioscler Thromb Vasc Biol 2001 2l 2051 2058 (Pubitemid 34219761)
8. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, Taskinen M, Groop L, Diabetes Care 2001 24 683 689 10.2337/diacare.24.4.683 11315831 (Pubitemid 32893993)
9. Cardiovascular risk factors. Insights from Framingham Heart Study. ODonnell C, Elosua R, Rev Esp Cardiol 2008 61 299 310 10.1157/13116658 18361904 (Pubitemid 351934113)
10. Cardiovascular disease: a comprehensive primer for clinicians. Dayspring T, Menopause Management 2002 11 1 9
11. The Effects of Menopause on the Serum Lipid Profile of Normal Females of South East Nigeria. Igweh J, Nwagha I, Okaro J, Nigerian Journal Physiological Sciences 2005 20 48 53
12. Fleiss JL, Tytun A, Ury HK, Biometrics 1980 36 343 346 10.2307/2529990
13. Van Belle G, Statistical Rule of Thumb New York: Wiley Interscience second 2008
14. Metabolic Syndrome and Menopause: Cross-sectional Study in Gynaecology Clinic. Neto J, Figueredo E, Barbosa J, Barbosa F, Costa G, Nina V, Nina R, Universidade Federal do Maranhao 2010, Sep 95 3 339 345
15. Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma without use of the Preparative Ultra-Centrifuge. Friedewald W, Levy R, Fredriskson D, Clin Chem 1972 18 499 502 4337382
16. Determination of blood glucose using an oxidase peroxidase system with a non- carcinogenic chromogen. Trinder P, J Clin Pathol 1969 22 158 161 10.1136/jcp.22.2.158 5776547
17. Metabolic syndrome: History synonyms and definition(s) Ed. Parihar M, Published by IMS Education Committee, Mumbai. Vaidya R, Pandey S, Srinivas M, Nabar N, IMS Digest 2011 1 2 5
18. Harmonizing the metabolic syndrome: A joint interim statement of the international Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International association for the Study of Obesity. Alberti K, Eckel R, Grundy S, Zimmet P, Cleeman J, Donato K, Circulation 2009 120 1640 1645 10.1161/CIRCULATIONAHA.109. 192644 19805654
19. The meaning and use of the area under a Receiver Operating Characteristic (ROC) curve. Hanley J, McNeil B, Radiology 1982 143 29 36 7063747 (Pubitemid 12142173)
20. Bonferroni CE, Il calcolo delle assicurazioni su gruppi di teste In Studi in Onore del Professore Salvatore Ortu Carboni.Rome: Italy 1935
21. Risks of CHD identified by Different Criteria of Metabolic Syndrome and Related Changes of Adipocytokines In Elderly Postmenopausal Women. Ding Q, Hayashi T, Zhang X, J Diabetes Complications 2007 21 315 319 10.1016/j.jdiacomp.2006.03.005 17825756 (Pubitemid 47354230)
22. Metabolic syndrome after menopause and the role of hormones. Lobo R, Maturitas 2008 60 10 18 10.1016/j.maturitas.2008.02.008 18407440
23. Sex differences in the regulation of body weight. Shi H, Cleqq D, Physiol Behav 2009 97 199 204 10.1016/j.physbeh.2009.02.017 19250944
24. Contribution of visceral obesity to the deterioration of the metabolic risk profile in men with impaired glucose tolerance. Pascot A, Despres J, Letnieux I, Diabetologia 2000 43 1126 1135 10.1007/s001250051503 11043858
25. Metabolic Obesity: The Paradox Between Visceral and Subcutaneous Fat. Hamdy O, Porramatikul S, Al-Ozairi E, Current Diabetes Reviews 2006 2 1 7 10.2174/157339906775473608 (Pubitemid 44082945)
26. Abdominal obesity as important component of insulinresistance syndrome. Després J, Nutrition l993 9 452 459
27. Relationships between insulin metabolism, serum lipid profile, body fat distributionand blood pressure in healthy men. Walton C, Lees B, Crook D, Godsland I, Stevenson I, Atherosclerosis 1995 118 35 43 10.1016/0021-9150(95) 05590-S 8579629
28. Obesity arid insulin resistance. Kahn B, Flier I, J Clin Invest 2000 106 473 481 10.1172/JCI10842 10953022
29. Central role of the adipocyte in insulin resistance. Bergman R, Mittleman S, J Basic Clin Physiol Pharmacol 1998 9 205 221 10212835 (Pubitemid 29143602)
30. Adiponectin, a new member of the family of soluble defense collagens, negatively regulated the growth of myelomonocytic progenitors and the functions of macrophage. Yokota T, Oritani K, Takahashi I, Blood Press 2000 96 1723 1732 (Pubitemid 30661055)
31. The Prevalence of Metabolic Syndrome in Chinese Postmenopausal Women and the Optimum Body Composition Indices to Predict It. Ruan X, Jin J, Hua L, Wang J, Liu S, Menopause: The Journal of the North American Menopause Society 2010 17 566 570
32. Metabolic Syndrome: a new world-wide definition: a consensus statement from the International Diabetes Federation. Alberti K, Zimmet P, Shaw J, Diabet Med 2006 23 469 480 16681555
33. Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Alberti K, Eckel R, Grundy S, Zimmet P, Cleeman J, Donato K, Fruchart J-C, James W, Loria C, Smith SJ, Circulation 2009 120 1640 1645 10.1161/CIRCULATIONAHA.109.192644 19805654
34. Predictive value of abdominal obesity cut-off points for hypertension in blacks from west African and Caribbean island nations. Okosun I, Rotimi C, Forrester T, Fraser H, Osotimehin B, Muna W, Cooper R, Int J Obes Relat Metab Disord 2000 24 180 186 10.1038/sj.ijo.0801104 10702768 (Pubitemid 30107566)
35. Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population. Liu C-S, Hsu H-S, Li C-I, Jan C-I, Li T-C, Lin W-Y, Lin T, Chen Y-C, Lee C-C, Lin C-C, BMC Gastroenterol 2011 10 51
36. WHO, Obesity: prevention and managing the global epidemic, Report of a WHO consultation on obesity, WHO/NUT/NCD/98.1 Geneva: WHO 1998
37. Obesity: Preventing and managing the global epidemic. World, Health, Organization, In Report of a WHO Consultation of obesity Geneva: World Health Organization 1998 1-1-9950
38. Measuring the accuracy of diagnostic systems. Swets J, Science 1988 240 1285 1293 10.1126/science.3287615 3287615
39. The mechanism of HDL lowering in hypertriglyceridemic, insulin-resistant states. Rashid S, Uffelman K, Lewis G, J Diabetes Complications 2002 16 24 28 10.1016/S1056-8727(01)00191-X 11872362 (Pubitemid 34168496)
40. Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity. Pascot A, Lemieux I, Prudhomme D, Tremblay A, Nadeau A, Couillard C, Bergeron J, Lamarche B, Despres J, J Lipid Res 2001 42 2007 2014 11734573 (Pubitemid 34001049)
41. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Lemieux I, Pascot A, Prudhomme D, Almeras N, Bogaty P, Nadeau A, Bergeron J, Despres J, Arterioscler Thromb Vasc Biol 2001 21 961 967 10.1161/01.ATV.21.6.961 11397704 (Pubitemid 34168653)
42. Abdominal obesity, muscle composition, and insulin resistance in premenopausal women. Ross R, Freeman J, Hudson R, Janssen I, J Clin Endocrinol Metab 2002 87 5044 5051 10.1210/jc.2002-020570 12414870 (Pubitemid 35316344)
43. Is visceral adipose tissue a determinant of von Willebrand factor in overweight and obese premenopausal women? Mertens I, Van der Planken M, Corthouts B, Van Gaal L, Metabolism 2006 55 650 655 10.1016/j.metabol.2006.01. 001 16631442
44. The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Nieves D, Cnop M, Retzlaff B, Walden C, Brunzell J, Knopp R, Kahn S, Diabetes 2003 52 172 179 10.2337/diabetes.52.1.172 12502509 (Pubitemid 36042123)
45. Prevalence and trends in Obesity among US Adults, 1999-2000. Flegal K, Carroll M, Ogden C, Johnson C, Jama 2002 288 1723 1727 10.1001/jama.288.14.1723 12365955
46. Association of Hip and Thigh Circumferences Independent of Waist Circumference with the Incidence of Type 2 Diabetes: the Horn Study. Snijder M, Dekker J, Visser M, Bouter L, Stehouwer C, Kostense P, Yudkin J, Heine R, Nijpels G, Seidell J, Am J Clin Nutr 2003 77 1192 1197 12716671 (Pubitemid 44858435)
47. Racial differences in insulin resistance and mid-thigh fat deposition in postmenopausal women. Ryan A, Nicklas B, Berman D, Obes Res 2002 10 336 344 10.1038/oby.2002.47 12006632 (Pubitemid 135688243)
48. Ghana Statistical Service, and, Macro, International, Inc, Preliminary Results Maryland: Claverton 2008 2009